This sweeping legislation, passed in late 2022 and now phased in, brings serious changes to how personal care products are developed, manufactured, and monitored in the U.S. It applies to a vast array of everyday products that most of us take for granted: your body lotion, shaving cream, makeup, face masks, and more.
Before MoCRA, the FDA had surprisingly limited authority over personal care products. Unlike drugs or medical devices, cosmetic products didn’t require premarket approval. For most items, there was no mandate for safety testing, no facility registration, and no system in place to report or track adverse reactions.
Take body lotion, for example. Unless the product made specific therapeutic claims (e.g., “heals eczema”), it wasn’t subject to rigorous scrutiny. Manufacturers often relied on Certificates of Analysis (COAs) from raw ingredient suppliers to validate safety, rather than conducting full clinical or toxicological tests. Major multinational personal care companies routinely performed additional safety evaluations, but many small-to-medium-sized brands did not. Who did, who didn’t? As a consumer, you probably wouldn’t know.
Contrast this with over-the-counter (OTC) personal care products, such as sunscreens, anti-dandruff shampoos, or fluoride toothpastes. These fall under FDA monographs—essentially a rulebook that defines acceptable ingredients, concentrations, labeling, and usage guidelines. Sunscreens, for example, may appear similar to body lotions, but they are treated entirely differently from a regulatory standpoint—they are regulated like drugs due to their interaction with the body, specifically their ability to protect against UV radiation, requiring them to follow a much more controlled regulatory process. (protecting against UV radiation).
That’s what makes MoCRA such a seismic shift. For the first time, all cosmetics and personal care manufacturers must:
- Register their manufacturing facilities with the FDA
- List every marketed product and its ingredients
- Substantiate product safety with robust data
- Report serious adverse events
- Comply with Good Manufacturing Practices (GMPs)
These are major asks, especially for smaller brands or independent startups that don’t have in-house regulatory teams.
So, that brings us to the big question:
Does More Regulation Help or Hurt Innovation?
The instinctive answer from many in industry might be “hurt.” More red tape, more cost, more time, more hurdles to getting a product to market. But the reality is more nuanced—and, arguably, more optimistic.
Yes, MoCRA raises the bar. Compliance requires investment in systems, documentation, testing, and traceability. It slows down the “move fast and break things” style of product development that some niche brands once leaned on.
But here’s the flip side: regulation creates pressure that fuels innovation.
Companies now need to find faster, more reliable, and more scalable ways to ensure product safety and compliance. That’s driving a wave of technological advancement behind the scenes—especially in AI, biotech, and digital infrastructure.
Consider the new wave of AI-powered formulation and compliance tools. Platforms like Centric Software, QT9 QMS, SmarterX, and Good Face Project are now helping brands:
- Automatically flag non-compliant ingredients across markets
- Simulate product safety using predictive modeling
- Maintain audit-ready documentation across multiple SKUs
- Track ingredient sourcing through blockchain-enabled traceability
Without MoCRA pushing the regulatory envelope, many of these capabilities might have remained niche or underdeveloped. Now, they’re becoming essential.
Here’s where it gets exciting: These tools aren’t just about compliance. They unlock new opportunities for innovation.
When your ingredient data is centralized and structured, it becomes easier to:
- Test new combinations quickly
- Design products for specific skin types or conditions
- Scale personalized beauty experiences
- Shorten the time from idea to shelf—without sacrificing safety
We’re already seeing early signs of this with the growth of biotech-driven skincare, microbiome-friendly formulations, and AI-driven product personalization.
A New Era for Product Developers
For the product developers in the personal care space, the journey has fundamentally changed.
Old Model:
- Get a trending ingredient
- Build a formula
- Do minimal stability and safety testing
- Launch fast, iterate if needed
New Model:
- Start with regulatory-compliant ingredients
- Use AI platforms to assess safety, compliance, and efficacy from day one
- Collaborate with QA, regulatory, and marketing teams earlier
- Design products that are not just safe, but provably safe
- Build documentation and traceability into every phase
This might seem like a burden, but it’s also an opportunity for product teams to gain more strategic influence within their companies. Innovation now means not just finding the next trendy ingredient, but designing responsibly, sustainably, and inclusively—all while staying ahead of evolving regulations.
In many ways, MoCRA is forcing the industry to grow up. And with maturity comes systems, structure, and yes—space to innovate.
So, does more regulation help or hurt innovation? When it’s designed well and paired with the right tools, regulation doesn’t stifle innovation—it shapes it. It gives it purpose, discipline, and ultimately, greater impact.
That said, recent leadership changes and staffing reductions at the FDA have introduced new uncertainty. While MoCRA remains legally in effect and the agency has demonstrated early enforcement, the loss of experienced personnel and administrative restructuring may delay the development of additional guidance and weaken oversight.
For brands, this means staying proactive. MoCRA compliance is not a box to check—it’s a framework for responsible innovation. And in a time of political flux, companies that build the systems, documentation, and agility to exceed the baseline will be the ones best positioned to lead.
Click here for more columns by Gail Martino; if you enjoy this content, please consider connecting with Gail Martino on LinkedIn.
